Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation programme
Prioritisation programme
HealthTech (4)
Interventional procedures (4)
Medicines evaluation (8)
None selected (367)
Decision
Decision
Awaiting decision (52)
Further information required (25)
Not selected (302)
Apply filters
Showing 81 to 90 of 383
Sort by
Decision date
Title
Apply sorting
Topic prioritisation
Title
Prioritisation programme
Decision
Decision date
Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]
None selected
Not selected
5 March 2025
Eptinezumab for preventing cluster headache attacks TSID 12087
None selected
Awaiting decision
21 February 2025
Paediatric lymphatic interventions (mainly Percutaneous thoracic duct embolisation) for Chylothorax, chylous ascites, plastic bronchitis, chylopericardium, Chyluria, Protein losing enteropathy
None selected
Not selected
13 February 2025
High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patients
None selected
Awaiting decision
5 February 2025
Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease
None selected
Awaiting decision
5 February 2025
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]
None selected
Not selected
4 February 2025
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]
None selected
Not selected
4 February 2025
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]
None selected
Not selected
4 February 2025
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]
None selected
Not selected
4 February 2025
Lebrikizumab for treating atopic dermatitis in children [TSID12133]
None selected
Not selected
4 February 2025
Previous page
1
…
7
8
Current page
9
10
11
…
39
Page
9
of
39
Next page
Results per page
10
25
50
All
Back to top